Malgorzata Girek
Lodz, LD, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
New cyclopentaquinoline and 3,5-dichlorobenzoic acid hybrids with neuroprotection against oxidative stress for the treatment of Alzheimer's disease.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: January 11, 2023
Synthesis and Biological Studies of Novel Aminophosphonates and Their Metal Carbonyl Complexes (Fe, Ru).
Journal: International journal of molecular sciences
Published: June 09, 2022
New Tetrahydroacridine Hybrids with Dichlorobenzoic Acid Moiety Demonstrating Multifunctional Potential for the Treatment of Alzheimer's Disease.
Journal: International journal of molecular sciences
Published: April 09, 2020
Biological assessment of new tetrahydroacridine derivatives with fluorobenzoic moiety in vitro on A549 and HT-29 cell lines and in vivo on animal model.
Journal: Human cell
Published: February 22, 2020
Novel tetrahydroacridine derivatives with iodobenzoic moieties induce G0/G1 cell cycle arrest and apoptosis in A549 non-small lung cancer and HT-29 colorectal cancer cells.
Journal: Molecular and cellular biochemistry
Published: January 20, 2019
Discovery of New Cyclopentaquinoline Analogues as Multifunctional Agents for the Treatment of Alzheimer's Disease.
Journal: International journal of molecular sciences
Published: December 03, 2018
New cyclopentaquinoline hybrids with multifunctional capacities for the treatment of Alzheimer's disease.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: December 07, 2017
Novel tetrahydroacridine derivatives with iodobenzoic acid moiety as multifunctional acetylcholinesterase inhibitors.
Journal: Chemical biology & drug design
Published: May 21, 2017
Tetrahydroacridine derivatives with dichloronicotinic acid moiety as attractive, multipotent agents for Alzheimer's disease treatment.
Journal: European journal of medicinal chemistry
Published: May 21, 2017
Tetrahydroacridine derivatives with fluorobenzoic acid moiety as multifunctional agents for Alzheimer's disease treatment.
Journal: Bioorganic chemistry
Published: November 01, 2016
Synthesis, biological evaluation and molecular modeling of new tetrahydroacridine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
Journal: Bioorganic & medicinal chemistry
Published: April 22, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026